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THE FIELD OF ALLERGY
by K. K. Adjepon-Yamoah, B.Sc.
A review based on a dissertation read before 
the Society on 10th December, 1965.
T h is  article concentrates on (i) the im m uno­
logical basis, (ii) pathophysiological m echan­
isms, and (iii) control (theoretical and practical) 
of the im m ediate-type allergy.
(a) the ‘im m ediate typ e ’ and (b) the ‘delayed 
type ’ reactions. Som e o f the main differences 
arc sum m arised below .
P A R T  I —  I M M U N O L O G I C A L  B A S IS
Introduction
A ntigen-antibody reactions constitute an 
im portant group o f defences, facilitating 
phagocytosis and blockin g the toxic effects of 
parasitic poisons. T h e  reaction confers 
‘im m u n ity ’. T h e  com bination  of antigen and 
antibody is, how ever, not always beneficial. 
Pathological reactions as severe or m ore severe 
than the affect o f the antigen alone arc som e­
times n oticed. H ypersensitivity or allergic re­
actions form  m ajor exam ples of such con­
ditions. A llergy or hypersensitivity m ay be 
defined as a state in w hich the animal reacts 
in an excessive w ay to the introduction of an 
antigen or a hapten even though the antigen 
or hapten may be innocuous. N o t all instances 
of hypersensitivity enjoy the identification of 
the exciting antigens, the m ediating antibodies 
and the m echanism s of tissue damage.
Classification
Experim entally tw o types o f hypersensitiv­
ity reactions can be dem onstrated." T h e y  are:
Immediate Type Delayed Type
1. Speed of 
onset of 
reaction 
follow ing 
antigen 
in troduc­
tion
Im m ediate D elayed 24-72 
hours
2. Type of 
an ti­
bodies
3. Chem ical 
m edi­
ators
y  - globulins A s yet 
Unidentified
H istam ine 
5 H T, SR S-A , 
? Bradykinin. 
(D epending on 
species)
A s yet 
Unidentified 
?  Bradykin in
4. Transfer 
from 
anim al 
to
animal
Possib le with 
serum  in many 
instances
N ot possible wilh 
serum . Possib le 
with cells in 
anim als. In man 
extracts of cells 
are effective.
5. Types Anaphylactic 
shock, A rthus 
reaction serum  
sickness, atrophy 
e.g. asthm a, som e 
drug sensitivity , 
A llergic rhinitis.
Bacterial allergy 
e.g. Tuberculin  
type reaction . 
C ontact sen sitiv­
ity to  sim ple 
chem ical, e.g. 
co n tact derm a­
titis.
ii
Anaphylaxis
Portier and Richet (1902) found that where­
as the first intravenous injection into dogs of 
an extract of sea anemones was relatively 
harmless, a second injection some 2 weeks 
later resulted in violent symptoms and often 
in the death of the dogs. Instead of ‘phylaxis’ 
(i.e. immunity), anaphylaxis developed. Soon 
Theobald, Sm ith, and Otto independently 
showed that the guinea pig could likewise be 
made hypersensitive even to non-poisonous ex­
tracts. T o  explain these facts two schools of 
thought developed. T h e  first and now defunct 
theory was the ‘anaphylatoxin hypothesis’ led 
by Portier and R ich et. T h e second and now 
widely accepted theory is the ‘cellular hypo­
thesis’ supported by Dale. Briefly, this cellular 
theory maintained that the anaphylactic re­
action was the result of union between antigen 
and antibody which had become ‘fixed’ to the 
living cell surface —  Dale and Schultz inde­
pendently showed that the phenomenon of 
anaphylaxis could be demonstrated in isolated 
tissues without the presence of blood. Dale 
showed that the uterus of a sensitised guinea 
pig (i.e. guinea pig which had received small 
injections of egg ovalbumin three weeks earlier), 
when suspended in a nutrient fluid at 37° C  
and oxygenated, would contract upon the 
addition to the bath of a small amount of the 
substance against which the guinea pig had 
been sensitised. T h e  effect was quite specific 
since unrelated antigens gave no reaction. 
Furthermore, after the uterus had once re­
sponded by contraction to the antigen in 
question, a second addition of the same amount 
of the same antigen produced no effect. T h e 
tissue had thus become desensitised. Other 
workers have shown that other smooth muscle 
strips from sensitised guinea pigs behave in 
the same 'Schultz-Dale ’ manner as the m yo­
metrium. It is now possible to sensitise guinea 
pig tissues passively by soaking them in anti­
body solution (e.g. I 133 labelled egg ovalbumin). 
There is ample evidence that antibody fixation 
to certain tissues is a necessary prerequisite for 
anaphylaxis.
Desensitisation
Guinea pigs sensitised to anaphylactic shock 
can be desensitised by repeated small injections 
of antigen. It has been shown that during the 
process of desensitisation a very high titre of 
circulating antibody is produced, and if antigen
is administered to such an im m une animal, 
anaphylactic reaction does not develop because 
the amount of circulating antibody is sufficient 
to neutralise all the injected antigen. Serum 
from such an immune animal is capable of 
inducing ‘passive’ sensitisation to anaphylaxis, 
thus demonstrating that the antibodies involv­
ed are of the same type.
Species variation
There is considerable species variation in the 
manifestations of generalised anaphylaxis. In 
the guinea pig there is severe bronchospasm 
leading to asphyxia and death. I n the rabbit 
death is ascribed to corpulmonale. In the 
dog, death is due to hepatic congestion and 
peripheral circulatory failure. M an resembles 
the guinea pig in that there is acute respiratory 
distress of asthmatic type and generalised 
oedema. Anaphylactic reaction in man is in 
fact rare but when it docs occur, it usually 
follows repeated injections of therapeutic 
serum (e.g. A T S ), or certain drugs (e.g. peni­
cillin and neoarsphenaminc).
There is experimental evidence that cot 
deaths, which are responsible for about 2,000 
infant deaths per year, may be due to hyper­
sensitivity to cow’s m ilk protein.
T h e  disturbances in generalised anaphylaxis 
arc fundam entally the same in all species. The 
main effects are: (a) spasm of smooth musclc, 
and (b) damage to endothelium of blood 
vessels and an increase in permeability, giving 
rise to generalised oedema.
Anaphylaxis has been used as an experi­
mental model in the study of allergy. T h e 
basic mechanisms are not fundam entally 
different from other types of immediate 
hypersensitivity.
Atopy, Food, D ust and Drug Sensitivity
This group of allergies occur after the in­
gestion of certain foods and drugs, the inhal­
ation of antigens like pollen, and the injection 
of drugs. There is considerable variation in 
symptomatology which seems to be dependent 
upon the route of absorption and the nature 
of the antigen or hapten.
Exam ples:
(a) Inhalation antigens, e.g. pollen, gives rise 
to respiratory symptoms such as allergic 
rhinitis, hay fever and asthma.
(b) Ingested substances, e.g. mushrooms, 
shellfish, give rise to gastro-intestinal symptoms 
and rashes. There is possibly absorption of
whole protein from the gut, so providing an 
antigen.
(c) In jected drugs, e.g. streptom ycin and 
p en icillin , usually give rise to skin rashes.
There seems to be a genetic basis in these 
types of allergy —  h ence the name atopy.
M iscellaneous  Exam ples
O ther examples of immediate hypersensitiv­
ity are  Arthus reaction and serum sickness, but 
these conditions seem to be dependent on 
antigen-antibody complexes.
M any diseases have been labelled allergic 
although their pathogeneses arc by no means 
clear. Exam ples arc T yp e I nephritis, rheum­
atic fever and polyarteritis nodosa. A  number 
of drug ‘diseases’ have also been documented 
as being allergic, and chlorpromazine obstruc­
tive jaundice is a well known example of this 
group.
P A R T  II M E C H A N IS M S
ANTIGEN +  FIXED ANTIBODY
EFFECTS ON CELL MEMBRANES
ACTIVATION OF ENZYMES 
(PHOSPHOLIPASE A AND CHYMO- 
TRYPSIN-LIKE ENZYMES)
ACTIVATION OF PROTEASES 
AND ESTERASES IN BLOOO
RELEASE OF 
HISTAMINE 
FROM MAST 
CELLS
OTHER SUBSTANCES, 
SRS-A  FORMATION. 
RELEASE OF HEPARIN 
ETC..5HT DEPENDING 
ON SPECIES
PEPTIDES 
(IN BLOOO)
I
KIMINS
HISTAMINE ?  
5  HT FROM 
PLATELETS 
(e g RABBIT)
ALLERGIC MANIFESTATIONS eg  LOW B. P.,
CONTRACTION OF SMOOTH MUSCLE, VASODILATION,
INCREASED CAPILLARY PERMEABILITY
SYMPTOMS OF ALLERGIC RESPONSE
Th e mechanism by which antigen-antibody 
combination brings about the release of phar­
macological agents is far from being well 
understood. Briefly —• antigen combines with 
fixed antibody. Th is ‘ reaction’ is believed to 
lead to activation of tissue enzyme systems 
which include chymotrypsin-like enzymes and 
phospholipase A (Austen and Brocklehurst, 
19 6 1, etc.). Com plem ent may or may not play 
a part at this stage.
Activated enzyme systems cause changes in 
the cells, such as mast cells which release 
pharmacologically active substances notably 
histamine, heparin, SR S-A , 5 H T , and brady- 
kinin. T h e  pattern of release is to some ex­
tent dependent on the species. T h e  activ­
ation of tissue protcases and esterases may act 
on substrates such as peptides in the blood to 
release vasoactive substances such as kinins.
Th e symptoms of hypersensitivity result from 
the actions of these pharmacological agents. 
A  summary of the evidence supporting the 
above statements is made below.
Enzym ic Participation
T h e influence here stems from indirect 
evidence in which the effects were observed 
of pH change, temperature change, calcium 
lack and specific enzyme inhibitors on certain 
standard tests, e.g. Schultz-Dale type of test. 
M ongar and Schild concluded (1962) that the 
enzymes were calcium requiring and heat 
labile.
Role of Histamine
As Schachter states “ Ever sincc that time that 
the similarity between the symptoms of hista­
mine intoxication and acute  anaphylactic shock 
was pointed out by Dale and Laidlaw (19 10) 
an impressive body of evidence im plicating 
histamine in anaphylaxis has accumulated.”  
M any workers have demonstrated the release 
of histamine from sensitised organs both in 
vitro  and in situ by specific antigen. Histamine 
liberators, e.g. 48/80, are able to reproduce 
many of the symptoms of anaphylactic shock 
when administered to animals. Schayer, and 
others, using radioactive histidine, have con­
cluded that not only do mast cells store hista­
mine, but also form histamine from histidine. 
Extrusion of mast cell granules, which arc 
thought to contain histam ine-heparin com­
plexes, have been observed during antigen- 
antibody reaction. T h e  evidence for the 
release of histamine in anaphylaxis is over­
whelming and the release of this substance has 
been assumed to occur also in other immediate- 
type allergic reactions.
Slow Reacting Substances of Anaphylaxis 
(SRS-A)
Kellaway and T reth ewie  (1940), reported 
the occurrence of a slow reacting substance 
from a sensitised tissue following a challenge
with an antigen. T h e  perfusate from guinea 
pig lung was assayed on guinea pig ileum and 
these workers recognised that the contraction 
differed from that caused by histamine in that 
the gut was slower to relax.
Brocklehurst (1952) noticed that high con­
centrations of antihistamines were unable to 
abolish SR S-A  response. SR S-A  does not 
appear to exist in preformed state, but is 
generated by events set in motion by antigen- 
antibody ‘reaction’ (Brocklehurst). In the 
tissues of sensitised guinea pigs and in human 
asthmatic lungs challenged with the appropri­
ate antigens SR S-A  is released along with 
histamine, but the peak release of SR S-A  
occurs later than that of histamine and more­
over the release of SR S-A  continues longer. 
SR S-A  can cause a strong and well-maintained 
contraction in isolated human bronchioles and 
it is presumed to play an important role in 
asthma and so to be as least part of the cause 
of therapeutic failures of antihistamines in this 
condition. H erxheimer and Stressman (196 1) 
have shown that whereas impure SRS-A  
aerosol decreased the vital capacity in asthmatic 
patients, it had only a small effect in normal 
subjects.
O ther Substances
5 H T  has been shown to be important in 
some species (rabbit and mouse) but not in 
man.
Bradykinin is present in the blood during 
anaphylaxis in several species of animals and 
can m im ic some of the changes which are not 
abolished by antihistamines and presumably 
cannot be attributed to histamine. An enzyme 
capable of form ing bradykinin in plasma, from 
dog plasma pseudoglobulin and from M awer 
Fraction C  is rapidly released from sensitised 
guinea pig lung or skin when these blood-free 
tissues are challenged with specific antigens 
(Brocklehurst).
Som e of the inflammatory changes accom­
panying antigen-antibody ‘interaction’ might be 
due to bradykinin generated locally.
PART III — CONTROL OF ALLERGY
Theoretically the allergic reaction can be 
prevented in a number of ways:—
(a) T h e  first anti-allergic step, often imprac­
tical, is the avoidance of contact with known 
antigens.
(b) By preventing antibody synthesis, e.g. by 
total body irradiation, antimetabolites and 
corticosteroids. T h e obvious disadvantages 
here far out-weigh any possible therapeutic 
advantages.
(c) B y preventing antibody fixation to tissues. 
(This has not been possible.)
(d) By inhibiting enzymes involved in the 
allergic process. Little is known about these 
cellular enzymes, although it is possible they 
have normal physiological functions, and so it 
follows that inhibition of these enzymes may 
interfere with some vital m etabolic processes 
(Brocklehurst, 1962).
(e) By dcsensitisation. T his method has 
been tried, but the results are often disappoint­
ing even when the existing antigen has been 
indentified.
(f) T h e  last, and at present most simple 
method of controlling the allergic symptoms 
is the inhibition or destruction of the pharma­
cological substances released during antigen- 
antibody ‘reaction’ .
There is 110 satisfactory way of antagonising 
SR S-A  although it has been reported that 
hom ochlorcyclizinc is a useful therapeutic 
agent in several allergic conditions including 
asthma. T his drug has m ultiple actions —  
anti 5H T , antihistamine, antiacetylcholine and 
weakly anti-SRS-A. It is therefore difficult to 
predict which action is responsible for the 
clinical improvement.
Theoretically there arc three ways in which 
a drug can oppose the actions of histamine:
(i) by physiological antagonism —  e.g. 
adrenaline which has many of its pharmaco­
logical actions opposite to those of histamine.
(ii) the drug m ight destroy histamine, e.g. 
formaldehyde, nitrates and the enzyme diamine 
oxidase. These drugs are of very limited 
therapeutic value.
(iii) by preventing histamine from reaching 
its site of action, e.g. by competition —  the 
antihistamines. T h e  last measure has proved 
to be the best therapeutic method of control­
ling the allergic reaction at present.
Antihistamines
These drugs oppose all the effects of injected 
histamine except that on gastric secretion. T h e 
use of antihistamines in allergy, however, has 
certain serious disadvantages. I shall summar­
ise these under three short paragraphs.
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Disadvantages o f the drugs. These include 
m ultiple actions of these antihistamines. All 
of them depress and sometimes stimulate the 
C .N .S . A bout 20%  of people on antihista­
mines complain of m inor and moderately 
severe side effects. Few  complain of serious 
side effects such as blood dyscrasias, the para­
doxical occurrence of hypersensitivity re­
actions.
Therapeutic uses of antihistamines. T h e 
best therapeutic results have been obtained 
in acute uticaria and seasonal hay fever. In 
perennial vasomotor rhinitis, chronic urticaria, 
angioneurotic oedema and allergic reactions to 
various allergens including drugs, the results of 
antihistamines are less gratifying. I n serum 
sickness they are of symptomatic value.
For acute anaphylactic reactions the anti­
histamines are not as effective as adrenaline or 
the corticosteroids. Antihistam ines have failed 
to benefit patients with bronchial asthma in 
spite of the undoubted allergic basis of the 
condition. Again these drugs have not been 
shown to be of any therapeutic value in the 
so-called allcrgic diseases like polyarteritis 
nodosa, acute rheumatic fever and type I 
nephritis.
Possible interference with a physiological 
role o f histam ine. Histamine is widely dis­
tributed in the organism. It is stored in a 
readily releasable form. Again, Schayer has 
shown recently that histamine is readily formed 
evern from tissue free of mast cells in response 
to stress. He has postulated a microcirculation 
regulator role for ‘ inducable’ histamine (which 
is perhaps stretching conclusions too far). 
Kahlson (1962) has also shown increased pro­
duction of ‘nascent’ histamine in rapidly- 
growing tissues, e.g. granulation tissue, tumour 
cells and rat embryos. M any other observ­
ations have forced Kahlson to conclude that
‘nascent’ histam ine formation is an integral 
part of the metabolism of certain rapidly 
growing tissues. I find it hard to believe that 
the presence of histamine in fire complicated 
and homeostatically balanced organism is 
simply to cause pathological changes. A 
physiological role for histamine is a very dis­
tinct possibility and has to be studied. Block­
ing the actions of histam ine in certain clinical 
situations may have other dangers and possibly 
what one gains on the roundabout is lost 0n 
the swings.
P A R T  IV  —  C O N C L U D IN G  R E M A R K S
T h e immunological basis of the allergic pro­
cess is undoubtedly proved, but the reaction 
sequence after antigen-antibody combination 
is still not clear. Progress has been made in 
the study of the pharmacological agents 
thought to be responsible for the alle rgic 
symptoms, but here too, there are gaps. W h y 
should the protective action of antigen and 
antibody combination result in detrimental 
reactions in certain individuals? Is this due 
to an inborn error? If  so, what is the basic 
biochemical abnormality that is involved? 
W h at is the agent responsible for the pro­
pagation of the allergic process once started? 
T h e  fertile soil of the delayed-type hyper­
sensitivity has not yet been cultivated.
It is estimated that about one person in ten 
in Great Britain suffers from one kind of 
allergy. It is also thought that in spite of in­
dividual susceptibility anyone is liable to de­
velop a type of hypersensitivity reaction if 
exposed to the antigen for a certain time. 
A llergic reactions to drugs and antitoxins pose 
more problems in therapeutics. M any of these 
considerations given above make a thorough 
understanding of the allergic process highly 
desirable.
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